Bank of New York Mellon Corp Sells 82,522 Shares of Humana Inc. (NYSE:HUM)

Bank of New York Mellon Corp cut its holdings in Humana Inc. (NYSE:HUM) by 10.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 737,499 shares of the insurance provider’s stock after selling 82,522 shares during the period. Bank of New York Mellon Corp’s holdings in Humana were worth $187,111,000 as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in HUM. Creative Financial Designs Inc. ADV grew its holdings in Humana by 244.0% in the 3rd quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock valued at $27,000 after buying an additional 61 shares during the last quarter. Ashton Thomas Securities LLC bought a new position in Humana during the third quarter worth $31,000. FPC Investment Advisory Inc. acquired a new position in Humana during the 4th quarter valued at $27,000. Centricity Wealth Management LLC bought a new stake in Humana in the 4th quarter valued at $30,000. Finally, Atwood & Palmer Inc. grew its position in Humana by 64.5% in the 4th quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider’s stock worth $39,000 after purchasing an additional 60 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Wall Street Analysts Forecast Growth

HUM has been the subject of a number of research analyst reports. Bank of America raised shares of Humana from an “underperform” rating to a “neutral” rating and upped their price objective for the company from $247.00 to $308.00 in a research report on Wednesday, November 6th. JPMorgan Chase & Co. cut their price target on Humana from $257.00 to $256.00 and set a “neutral” rating for the company in a report on Tuesday, February 18th. Piper Sandler lifted their price objective on Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a report on Wednesday, January 15th. Barclays upped their target price on Humana from $255.00 to $270.00 and gave the company an “equal weight” rating in a research note on Thursday, February 13th. Finally, StockNews.com upgraded shares of Humana from a “hold” rating to a “buy” rating in a research note on Tuesday. Nineteen investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $285.68.

Insider Buying and Selling at Humana

In other news, insider Timothy S. Huval sold 3,703 shares of the company’s stock in a transaction on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the transaction, the insider now owns 8,181 shares of the company’s stock, valued at $2,096,463.06. This represents a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 0.32% of the company’s stock.

Humana Stock Performance

Humana stock opened at $261.49 on Friday. The stock has a 50-day simple moving average of $270.64 and a 200 day simple moving average of $287.87. The stock has a market capitalization of $31.55 billion, a price-to-earnings ratio of 26.28, a P/E/G ratio of 2.05 and a beta of 0.56. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $406.46.

Humana (NYSE:HUM) last announced its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, topping analysts’ consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. On average, research analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be issued a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.35%. The ex-dividend date of this dividend is Friday, March 28th. Humana’s dividend payout ratio is 35.58%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.